Antiretroviral (ARV) medications

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Universitas Sebelas Maret

Conditions

HIV InfectionsHuman Immunodeficiency Virus (HIV)

Phase 1

Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents

CompletedNCT03332095

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2018-07-02End: 2022-05-25Updated: 2023-02-14

Unknown Phase

Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 Counts

CompletedNCT07553052

Universitas Sebelas MaretHuman Immunodeficiency Virus (HIV)

Start: 2025-06-01End: 2025-09-30Updated: 2026-04-27